MX2012004338A - Formulaciones mejoradas. - Google Patents

Formulaciones mejoradas.

Info

Publication number
MX2012004338A
MX2012004338A MX2012004338A MX2012004338A MX2012004338A MX 2012004338 A MX2012004338 A MX 2012004338A MX 2012004338 A MX2012004338 A MX 2012004338A MX 2012004338 A MX2012004338 A MX 2012004338A MX 2012004338 A MX2012004338 A MX 2012004338A
Authority
MX
Mexico
Prior art keywords
canister
particles
metering valve
improved formulations
formulation
Prior art date
Application number
MX2012004338A
Other languages
English (en)
Inventor
Rudi Mueller-Walz
Lise-Marie Fueg
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41462451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012004338(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jagotec Ag filed Critical Jagotec Ag
Publication of MX2012004338A publication Critical patent/MX2012004338A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

En un inhalador de dosis medida, que comprende una lata y válvula dosificadora, que contiene una formulación en aerosol en suspensión que comprende partículas de fumarato de formoterol dihidratado y propionato de fluticasona suspendidas en un propelente de HFA, un método para reducir la deposición de partículas sobre la superficie de la lata y la válvula dosificadora, el método comprende el paso de agregar un agente humectante a la formulación.
MX2012004338A 2009-10-16 2010-10-15 Formulaciones mejoradas. MX2012004338A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0918150.4A GB0918150D0 (en) 2009-10-16 2009-10-16 Improved formulations
PCT/EP2010/065569 WO2011045429A1 (en) 2009-10-16 2010-10-15 Improved formulations

Publications (1)

Publication Number Publication Date
MX2012004338A true MX2012004338A (es) 2012-08-01

Family

ID=41462451

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004338A MX2012004338A (es) 2009-10-16 2010-10-15 Formulaciones mejoradas.

Country Status (24)

Country Link
US (2) US20120263766A1 (es)
EP (2) EP3811928A1 (es)
JP (2) JP5818801B2 (es)
CN (1) CN102573791B (es)
AU (1) AU2010305695B2 (es)
BR (1) BR112012008969B1 (es)
CA (1) CA2776845C (es)
CL (1) CL2012000948A1 (es)
CY (1) CY1123918T1 (es)
DK (1) DK2488157T3 (es)
ES (1) ES2859629T3 (es)
GB (1) GB0918150D0 (es)
HR (1) HRP20210379T1 (es)
HU (1) HUE054030T2 (es)
IL (2) IL219162A0 (es)
LT (1) LT2488157T (es)
MX (1) MX2012004338A (es)
NZ (1) NZ599900A (es)
PL (1) PL2488157T3 (es)
PT (1) PT2488157T (es)
RS (1) RS61430B1 (es)
SI (1) SI2488157T1 (es)
WO (1) WO2011045429A1 (es)
ZA (1) ZA201202595B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301676B6 (cs) * 2001-03-30 2010-05-19 Jagotec Ag Farmaceutický suspenzní aerosolový prípravek pro inhalaci a použití soli karboxylové kyseliny
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
JP6335798B2 (ja) * 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
KR20150002774A (ko) 2012-04-11 2015-01-07 시플라 리미티드 아르포르모테롤 및 플루티카손 푸로에이트를 포함하는 약학 조성물
GB201321712D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
CN105963282B (zh) * 2016-05-04 2019-04-19 四川普锐特医药科技有限责任公司 一种医用定量吸入气雾剂
WO2018059390A1 (zh) * 2016-09-29 2018-04-05 广东东阳光药业有限公司 药物组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
WO1996032150A1 (en) 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Metered dose inhaler for salmeterol
DK0820279T3 (da) 1995-04-14 2002-10-07 Smithkline Beecham Corp Dosisudmålende inhalator til Albuterol
JPH101442A (ja) * 1996-06-12 1998-01-06 Taisho Pharmaceut Co Ltd 鼻炎用点鼻薬
WO1998041193A1 (en) * 1997-03-20 1998-09-24 Schering Corporation Preparation of powder agglomerates
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
ME00220B (me) * 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
US20030207057A1 (en) 2000-09-18 2003-11-06 Britto Ignatius Loy Metered dose inhaler can coated two or more times with fluorocarbon polymers
PL199420B1 (pl) * 2000-10-09 2008-09-30 3M Innovative Properties Co Medyczne preparaty aerozolowe
CZ301676B6 (cs) * 2001-03-30 2010-05-19 Jagotec Ag Farmaceutický suspenzní aerosolový prípravek pro inhalaci a použití soli karboxylové kyseliny
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
GB0201400D0 (en) * 2002-01-22 2002-03-13 Glaxo Group Ltd Novel apparatus and process
EP2319584A1 (en) * 2002-08-29 2011-05-11 Cipla Ltd. Pharmaceutical products and compositions comprising salmeterol, ciclesonide and tiotropium
GB0323684D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0327727D0 (en) * 2003-11-28 2003-12-31 Quadrant Drug Delivery Ltd Viral microparticles
GB0410399D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations

Also Published As

Publication number Publication date
GB0918150D0 (en) 2009-12-02
HUE054030T2 (hu) 2021-08-30
JP2016040286A (ja) 2016-03-24
PL2488157T3 (pl) 2021-06-28
CN102573791A (zh) 2012-07-11
CN102573791B (zh) 2017-09-22
DK2488157T3 (da) 2021-01-25
PT2488157T (pt) 2021-02-05
JP2013507429A (ja) 2013-03-04
US20180296468A2 (en) 2018-10-18
CA2776845C (en) 2018-04-24
WO2011045429A1 (en) 2011-04-21
CA2776845A1 (en) 2011-04-21
BR112012008969B1 (pt) 2021-07-06
IL269369A (en) 2019-11-28
JP5818801B2 (ja) 2015-11-18
US20120263766A1 (en) 2012-10-18
ZA201202595B (en) 2023-07-26
CL2012000948A1 (es) 2012-12-14
US20170281529A1 (en) 2017-10-05
SI2488157T1 (sl) 2021-02-26
AU2010305695A1 (en) 2012-05-03
HRP20210379T1 (hr) 2021-04-16
ES2859629T3 (es) 2021-10-04
AU2010305695B2 (en) 2014-07-10
EP3811928A1 (en) 2021-04-28
BR112012008969A2 (pt) 2020-06-23
NZ599900A (en) 2014-11-28
LT2488157T (lt) 2021-02-10
RS61430B1 (sr) 2021-03-31
EP2488157B1 (en) 2020-12-30
IL219162A0 (en) 2012-06-28
EP2488157A1 (en) 2012-08-22
CY1123918T1 (el) 2022-05-27

Similar Documents

Publication Publication Date Title
MX2012004338A (es) Formulaciones mejoradas.
PH12017500778A1 (en) COMPOSITIONS, METHODS and SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
MX2013013440A (es) Composiciones, metodos y sistemas para suministro respiratorio de dos o mas agentes activos.
TN2012000269A1 (en) Combination therapy for copd
GB201210580D0 (en) Metered dose dispensing valve
MX2014004279A (es) Composiciones que comprenden sulfato de salbutamol.
MX336225B (es) Composiciones que comprenden sulfato de salbutamol.
WO2011076841A3 (en) Combination therapy for copd
MX2010003935A (es) Suministro de farmaco por inhalacion.
AU2010303040A8 (en) Improvements to pressurised metered dose inhalers
MX357619B (es) Inhalador que comprende una composición que contiene tiotropio.
MX2015016058A (es) Composiciones, metodos y sistemas para el suministro por via respiratoria de tres o mas agentes activos.
PH12014502746B1 (en) Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same
WO2010011329A3 (en) The delivery of powdered drug via inhalation
TR201000680A2 (tr) Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
MX2015015132A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
JP2014530231A5 (es)
MX370890B (es) Composición que comprende sulfato de salbutamol.
MD20140131A2 (ro) Doză şi formă preparativă nouă pentru inhalare care cuprinde aclidiniu
GB201118188D0 (en) Manufacture of medicinal aerosol canisters
JO3024B1 (ar) صيغ أيروسول صيدلانية من الفرموتيرول وبكلوميتازون داي بروبيونات
WO2011061498A3 (en) Inhalation solutions
MX2022008440A (es) Inhaladores de dosis medida presurizada que comprenden una formulacion farmaceutica amortiguada.
MY171271A (en) Method for preparing metered dose sprayed inhaler for treating respiratory disease
UA109530C2 (uk) Композиції, способи та системи для доставки респіраторним шляхом двох чи більше активних агентів

Legal Events

Date Code Title Description
GD Licence granted
GD Licence granted
FG Grant or registration